Safety Lancets Market Rising Demand in Diabetes Care and Home Diagnostics

Safety Lancets Market Size, Trends, Companies & Growth Factors

The safety lancets market was estimated at US$ 2.1 billion in 2023 and is projected to grow to US$ 6.32 billion by 2034, rising at a compound annual growth rate (CAGR) of 10.54% from 2024 to 2034.

Key Takeaways

• North America dominated the global safety lancets market in 2024.
• Asia Pacific is expected to be the fastest-growing during the forecast period.
• By type, the pressure-activated safety lancet segment dominated the market in 2024.
• By type, the side button safety lancet segment is estimated to be the fastest growing at a notable CAGR during the forecast period.
• By end user, the hospitals & clinics segment dominated the global safety lancets market in 2024.
• By end user, the home diagnostics segment is predicted to be the fastest growing during the forecast period.

Safety Lancets Market: Prioritizing Safety

Lancets are small, sharp needles used to puncture the skin to withdraw a minuscule quantity of blood. However, standard lancets carry the risk of needlestick injuries. Safety lancets are a safer alternative to standard lancets as they contain retractable needles, thereby preventing accidental pricks and reducing the risk of infection. Safety lancets are more specific and personalized to every patient type, as they can puncture and penetrate to a predetermined depth during sample collection. These lancets are commonly used to withdraw blood during blood glucose monitoring. They are also used in various tests such as lipid profiles, HbA1C, and blood typing.

The rising prevalence of chronic disorders like diabetes and cholesterol increases the demand for safety needles. The rising needlestick injuries from standard lancets promote the use of safety lancets. Additionally, technological advancements and the latest innovations in safety lancets boost market growth.

Safety Lancets Market Trends

• In April 2024, HTL-Strefa announced that it received expanded US FDA approval for its Droplet Micron 34G x 3.5 mm pen needle from prescription-only to over-the-counter use. Droplet Micron will also be used for subcutaneous injection of drugs, such as GLP-1 analogs, apart from insulin.
• The sales of B.Braun in 2023 were around 8,755 EUR million, a 3% increase from last year, out of which the gross profit was reported to be 3,322.4 EUR million. Also, B.Braun spent 484.6 EUR million in research & development in 2023.

Growth Factors

• Increasing occurrences of diseases: Various diseases are increasing, which require blood testing. This, in turn, increases the use of safety lancets.
• Adopting to safe use of lancets: By using regular lancets, there is a risk of growing infection, due to which the adoption of safety lancets is increasing.
• Growing homecare: The use of safety lancets in the home is rising as it offers safe and convent uses.

Blood Self-Sampling Devices Promote the Safety Lancets Market

The development of blood self-sampling devices or lancing devices increases the demand and use of safety lancets. These devices automatically collect blood samples from the skin, offering a standardized and safe approach to obtaining blood samples. This benefits children, the geriatric population, and adults having a fear of piercing their skin. Hence, the advent of self-sampling devices increases patient adherence. These devices enable interoperability and interface with the current total lab automation. Additionally, they are affordable, sustainable, and of high quality. The devices either collect blood from the upper arm or prick the finger. Blood sampling can maintain laboratory testing for patients who live far away from the hospital. The increasing investments in microfluidics and demand for safe, latest innovations and painless withdrawal of blood potentiate the market growth.

Lack of Awareness Hinder the Safety Lancets Market

Patients from numerous developing countries are unaware of the safety lancets for withdrawing capillary blood. Most of the people use conventional lancets as they are a cheaper alternative and easily available. Safety lancets are also not preferred due to pain, fear and anxiety. This hampers the market growth.

Regional Insights

Advanced Healthcare Infrastructure Dominated North America

North America held the largest share of the safety lancets market in 2023. The rising prevalence of diabetes and other disorders, advanced healthcare infrastructure, increasing investments, and technological advancements drive the market. In 2022, around 38.4 million people in the US and around 5.7 million people in Canada were suffering from both type 1 and 2 diabetes. According to the Centers for Disease Control and Prevention, more than half of the US citizens are suffering from cholesterol. The Occupational Safety and Health Administration promotes the use of safety lancets among healthcare workers who perform finger-prick blood sampling in the workplace to prevent needlestick injuries. The Canadian Government governs the use of glucometers, test strips, and lancets for regular monitoring of blood glucose levels with an aim to prevent serious diabetes complications and long-term hospitalizations. The market is also driven by increasing awareness, and the presence of key players augment market growth.

Rising Prevalence of Diabetes Drives Asia-Pacific

Asia-Pacific is projected to host the fastest-growing safety lancets market in the coming years. The rising geriatric population, increasing prevalence of diabetes and other chronic illnesses, increasing investments, and demand for point-of-care diagnostics drive the market. The rising prevalence of chronic disorders potentiates regular testing for these disorders, thereby increasing the demand for safety lancets. China accounts for more than half of the familial hypercholesterolemia cases in the world. In the Asia-Pacific region, familial hypercholesterolemia accounts for almost 15 million cases. Several organizations conduct training sessions to increase awareness of the use of safety lancets in the region.

Increasing Disease Incidence and Homecare Adoption in Europe

Europe is expected to grow significantly in the safety lancets market during the forecast period. The increasing diseases is increasing the use as well as demand for the safety lancets in Europe. At the same time, due to their easy and safe use, their adoption in homecare settings is also increasing.

The growing incidence of diseases is increasing the use of safety lancets in the healthcare sector. Furthermore, due to its advantages of reducing the risk of infections, it also contributes to the same. Thus, all these factors promote the market growth.

The industries in Germany are focusing on the development of safety lancets due to their increasing use. At the same time, its use in the homecare setting is also rising as they are easy to use. This, in turn, is also supported by the government.

Segmental Insights

By type, the pressure-activated safety lancet segment held the largest share in the safety lancets market in 2023. A pressure-activated safety lancet is a device that withdraws blood by placing it on the finger and applying very little pressure, enabling the needle to prick the skin and retract it. It does not contain a button to aid the needle to come out. It is widely preferred due to its simplicity, sterility, and pain-masking ability. It increases patient adherence as it offers safety and comfort for the patient.

The side button safety lancet segment is projected to expand rapidly in the safety lancet market in the coming years. A side button safety lancet consists of a button that automatically retracts and locks, protecting against accidental needlestick injuries. Its spring-loaded action helps ensure a swift, gentle action with controlled penetration.

By end-use, the hospitals & clinics segment registered its dominance over the global market in 2023. Hospitals & clinics have sufficient facilities and tools for point-of-care diagnosis. Numerous patients prefer hospitals & clinics for testing purposes as they are governed by stringent regulations and provide high-quality testing services. Additionally, hospitals & clinics have suitable facilities for disposing of the safety lancets. In hospitals & clinics, patients can undergo blood testing for several other disorders, but at-home care testing is not available.

The home diagnostics segment is expected to grow at the fastest rate in the market during the forecast period. Home diagnostics are the most preferred option for geriatric patients. The availability of at-home care testing devices for blood glucose monitoring and HbA1C levels potentiates the market growth.

Recent Development in the Safety Lancets Market

• In September 2022, Tasso announced that it had received 510(k) clearance for its lancet product, Tasso+, to enable blood collection at home. The blood collection is initiated by just pressing a button on the device to release a lancet.
• In December 2023, Becton, Dickinson, and Co. (BD) received FDA authorizations for their two blood draw devices from the BD MiniDraw Capillary Blood Collection System series. The blood is withdrawn from a capillary level using a lancet integrated into the device.

Top Companies in the Safety Lancets Market

• Accurex Biomedical Pvt. Ltd.
• B.Braun
• Biosense Technologies
• Cardinal Health
• Ethitech Health Innovation
• Greiner Bio-One
• HemoCue AB
• ICU Medical
• Microdot
• Owen Mumford
• Phoenix Healthcare Solutions, LLC
• Sarstedt, Inc.

Segments Covered in the Report

By Type

• Pressure Activated Safety Lancet
• Side Button Safety Lancet
• Push Button Safety Lancet

By End-Use

• Hospitals & Clinics
• Home Diagnostics
• Diagnostic Centers
• Pathology Laboratories
• Others

By Region

• North America
  • US
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Thailand
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait